| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT05492578 Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous… |
Trial sites expanded: 378 -> 388 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06241118 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background… | Dermatitis Atopic | Recruiting |
| NCT06407934 | A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of… | Dermatitis Atopic | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05492578 | Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous… | Dermatitis Atopic | Enrolling by Invitation |
| Phase 2 | |||
| NCT06195072 | Platform Clinical Study for Conquering Scleroderma | Interstitial Lung Disease Due to Systemic Disease | Recruiting |
| NCT06557772 | A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With… | Coeliac Disease | Active, Not Recruiting |
| NCT05769777 | Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in… | Dermatitis Atopic | Active, Not Recruiting |
| NCT06033833 | Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult… | Asthma | Active, Not Recruiting |